WO2007112136A3 - Methods and systems for treating injured cardiac tissue - Google Patents
Methods and systems for treating injured cardiac tissue Download PDFInfo
- Publication number
- WO2007112136A3 WO2007112136A3 PCT/US2007/060060 US2007060060W WO2007112136A3 WO 2007112136 A3 WO2007112136 A3 WO 2007112136A3 US 2007060060 W US2007060060 W US 2007060060W WO 2007112136 A3 WO2007112136 A3 WO 2007112136A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cardiac tissue
- systems
- methods
- treating injured
- injured cardiac
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/19—Platelets; Megacaryocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4833—Thrombin (3.4.21.5)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/19—Syringes having more than one chamber, e.g. including a manifold coupling two parallelly aligned syringes through separate channels to a common discharge assembly
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/20—Applying electric currents by contact electrodes continuous direct currents
- A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
- A61N1/303—Constructional details
- A61N1/306—Arrangements where at least part of the apparatus is introduced into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/325—Applying electric currents by contact electrodes alternating or intermittent currents for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body
Abstract
Methods and systems are disclosed for treating cardiac tissue by delivering a platelet composition which induces neovascularization in the cardiac tissue followed by a cell preparation which induces regeneration in the re-vascularized tissue. The platelet composition can additionally contain structural materials and/or bioactive agents.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07756277A EP2007404A2 (en) | 2006-03-23 | 2007-01-03 | Methods and systems for treating injured cardiac tissue |
JP2009501617A JP2009530412A (en) | 2006-03-23 | 2007-01-03 | Methods and methods for treating damaged heart tissue |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74368606P | 2006-03-23 | 2006-03-23 | |
US60/743,686 | 2006-03-23 | ||
US11/426,211 | 2006-06-23 | ||
US11/426,219 | 2006-06-23 | ||
US11/426,219 US20070014784A1 (en) | 2005-06-23 | 2006-06-23 | Methods and Systems for Treating Injured Cardiac Tissue |
US11/426,211 US20070042016A1 (en) | 2005-06-23 | 2006-06-23 | Methods and Systems for Treating Injured Cardiac Tissue |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007112136A2 WO2007112136A2 (en) | 2007-10-04 |
WO2007112136A3 true WO2007112136A3 (en) | 2007-11-29 |
Family
ID=56290896
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/060059 WO2007112135A2 (en) | 2006-03-23 | 2007-01-03 | Methods and systems for treating injured cardiac tissue |
PCT/US2007/060060 WO2007112136A2 (en) | 2006-03-23 | 2007-01-03 | Methods and systems for treating injured cardiac tissue |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/060059 WO2007112135A2 (en) | 2006-03-23 | 2007-01-03 | Methods and systems for treating injured cardiac tissue |
Country Status (3)
Country | Link |
---|---|
EP (2) | EP2007403A2 (en) |
JP (2) | JP2009530411A (en) |
WO (2) | WO2007112135A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6811777B2 (en) | 2002-04-13 | 2004-11-02 | Allan Mishra | Compositions and minimally invasive methods for treating incomplete connective tissue repair |
US8057426B2 (en) | 2007-01-03 | 2011-11-15 | Medtronic Vascular, Inc. | Devices and methods for injection of multiple-component therapies |
WO2010042658A1 (en) | 2008-10-07 | 2010-04-15 | Bioparadox, Llc | Use of platelet rich plasma composition in the treatment of cardiac conduction abnormalities |
EP2337617A4 (en) * | 2008-10-09 | 2013-06-12 | Bioparadox Llc | Platelet rich plasma formulations for cardiac treatments |
IL210162A0 (en) | 2010-12-21 | 2011-03-31 | Omrix Biopharmaceuticals | Viral inactivated platelet extract, use and preparation thereof |
US20140356893A1 (en) | 2013-06-04 | 2014-12-04 | Allan Mishra | Compositions and methods for using platelet-rich plasma for drug discovery, cell nuclear reprogramming, proliferation or differentiation |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030007957A1 (en) * | 2001-07-03 | 2003-01-09 | Calvin Britton | Novel wound healing composition not containing bovine-derived activating reagents |
WO2004084825A2 (en) * | 2003-03-24 | 2004-10-07 | Harch Paul M D | Wound healing composition derived from low platelet concentration plasma |
US20050209564A1 (en) * | 2001-01-13 | 2005-09-22 | Medtronic, Inc. | Devices and methods for interstitial injection of biologic agents into tissue |
US20060041243A1 (en) * | 2001-01-13 | 2006-02-23 | Medtronic, Inc. | Devices and methods for interstitial injection of biologic agents into tissue |
-
2007
- 2007-01-03 WO PCT/US2007/060059 patent/WO2007112135A2/en active Application Filing
- 2007-01-03 EP EP07756276A patent/EP2007403A2/en not_active Withdrawn
- 2007-01-03 WO PCT/US2007/060060 patent/WO2007112136A2/en active Application Filing
- 2007-01-03 JP JP2009501616A patent/JP2009530411A/en active Pending
- 2007-01-03 JP JP2009501617A patent/JP2009530412A/en active Pending
- 2007-01-03 EP EP07756277A patent/EP2007404A2/en not_active Withdrawn
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050209564A1 (en) * | 2001-01-13 | 2005-09-22 | Medtronic, Inc. | Devices and methods for interstitial injection of biologic agents into tissue |
US20060041243A1 (en) * | 2001-01-13 | 2006-02-23 | Medtronic, Inc. | Devices and methods for interstitial injection of biologic agents into tissue |
US20030007957A1 (en) * | 2001-07-03 | 2003-01-09 | Calvin Britton | Novel wound healing composition not containing bovine-derived activating reagents |
WO2004084825A2 (en) * | 2003-03-24 | 2004-10-07 | Harch Paul M D | Wound healing composition derived from low platelet concentration plasma |
Non-Patent Citations (3)
Title |
---|
ANITUA E ET AL: "Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture", JOURNAL OF ORTHOPAEDIC RESEARCH, THE JOURNAL OF BONE AND JOINT SURGERY, INC.,, US, vol. 23, no. 2, March 2005 (2005-03-01), pages 281 - 286, XP004763650, ISSN: 0736-0266 * |
KUHN D F M ET AL: "Novel therapeutic options due to autologous blood components - Exemplified by autologous platelet gel", TRANSFUSION MEDICINE AND HEMOTHERAPY, vol. 33, no. 4, August 2006 (2006-08-01), pages 307 - 313, XP008083237, ISSN: 1660-3796 * |
MOGAN C ET AL: "Rationale of platelet gel to augment adaptive remodeling of the injured heart", JOURNAL OF EXTRA-CORPOREAL TECHNOLOGY 2004 UNITED STATES, vol. 36, no. 2, 2004, pages 191 - 196, XP008083236, ISSN: 0022-1058 * |
Also Published As
Publication number | Publication date |
---|---|
EP2007403A2 (en) | 2008-12-31 |
WO2007112136A2 (en) | 2007-10-04 |
JP2009530412A (en) | 2009-08-27 |
WO2007112135A3 (en) | 2007-11-22 |
WO2007112135A2 (en) | 2007-10-04 |
EP2007404A2 (en) | 2008-12-31 |
JP2009530411A (en) | 2009-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006083991A3 (en) | Fiber-reinforced composite absorbable endoureteral stent | |
HK1134041A1 (en) | Medicinal composition for transdermal absorption, medicinal composition storing unit and transdermal absorption preparation using the same | |
IL183357A0 (en) | Oral medicament for the modified release of at least one active principle, in multimicrocapsule form | |
IL221795B (en) | Use of a pharmaceutical composition of methylnaltrexone, or a salt thereof, in the preparation of a medicament for treating the side effects of opioid treatment | |
WO2006052451A3 (en) | Implantable collagen compositions | |
HK1184701A1 (en) | Use of glycosaminoglycan containing a binded hydrophobic group in the preparation of medicine for treating or preventing corneal epithelial layer disorders | |
GB0721331D0 (en) | Implantable materials and methods for inhibiting tissue adhesion formation | |
BRPI0911681A2 (en) | compound, pharmaceutical composition, and method for activating the 5'-amp activated protein kinase pathway in a cell | |
EP1928367A4 (en) | Prosthetic leg having electronically controlled prosthetic knee with regenerative braking feature | |
WO2007038246A3 (en) | Solid polymer delivery compositions and methods for use thereof | |
EP2051658A4 (en) | Composite implants for promoting bone regeneration and augmentation and methods for their preparation and use | |
IL207038A (en) | Diazaspiro[5.5]undecane derivatives, pharmaceutical compositions comprising the same and uses thereof in the preparation of medicaments for treating or reducing the risk of an inflammatory disease or condition | |
IL207546A0 (en) | Pharmaceutical composition for use in the treatment or prevention of osteoarticular diseases | |
WO2007112136A3 (en) | Methods and systems for treating injured cardiac tissue | |
WO2009040420A3 (en) | Use of a monoterpene to increase tissue repair | |
GB0700436D0 (en) | Impulse therapy for enhanced blood circulation in the body | |
EP2269653A4 (en) | Composition for stabilizing -blocker, and transdermally absorbable preparation comprising the composition | |
WO2009022133A3 (en) | Scaffolds | |
BRPI0819534A2 (en) | Pharmaceutical composition, method for treating HIV or AIDS and method for preparing a pharmaceutical composition, dosage form and composition " | |
PL2401263T3 (en) | Substituted azole derivatives, pharmaceutical composition containing the derivatives, and method for treating parkinson's disease using the same | |
ZA200808465B (en) | Pharmaceutical formulations:salts of 8-[{1-(3,5-bis (trifluoromethy1)pheny1)-e thoxy}-methy1]-8-pheny1-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same | |
HK1112848A1 (en) | Pharmaceutical composition for regenerating myofibers in the treatment of muscle injuries | |
WO2007103993A3 (en) | Bioactive scaffold for therapeutic and adhesion prevention applications | |
EP2502989A4 (en) | Implant composition for the regeneration of neural tissue, process of preparation and uses thereof | |
WO2007089688A3 (en) | Na/k-atpase ligand |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 2009501617 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007756277 Country of ref document: EP |